RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

The RA-MAP Consortium; (2022) RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients. Scientific Data , 9 , Article 196. 10.1038/s41597-022-01264-y. Green open access

[thumbnail of Ciurtin_s41597-022-01264-y.pdf]

Preview

Text
Ciurtin_s41597-022-01264-y.pdf
Download (2MB) | Preview

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disorder with poorly defined aetiology characterised by synovial inflammation with variable disease severity and drug responsiveness. To investigate the peripheral blood immune cell landscape of early, drug naive RA, we performed comprehensive clinical and molecular profiling of 267 RA patients and 52 healthy vaccine recipients for up to 18 months to establish a high quality sample biobank including plasma, serum, peripheral blood cells, urine, genomic DNA, RNA from whole blood, lymphocyte and monocyte subsets. We have performed extensive multi-omic immune phenotyping, including genomic, metabolomic, proteomic, transcriptomic and autoantibody profiling. We anticipate that these detailed clinical and molecular data will serve as a fundamental resource offering insights into immune-mediated disease pathogenesis, progression and therapeutic response, ultimately contributing to the development and application of targeted therapies for RA.

Type:	Article
Title:	RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1038/s41597-022-01264-y
Publisher version:	https://doi.org/10.1038/s41597-022-01264-y
Language:	English
Additional information:	This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI:	https://discovery.ucl.ac.uk/id/eprint/10141166